Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative Group

Eur J Cancer Clin Oncol. 1989 May;25(5):909-10. doi: 10.1016/0277-5379(89)90140-5.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Aged
  • Alkaloids / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma / drug therapy*
  • Drug Evaluation
  • Ellipticines / therapeutic use*
  • Female
  • Humans
  • Intercalating Agents / therapeutic use
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged

Substances

  • Alkaloids
  • Antineoplastic Agents
  • Ellipticines
  • Intercalating Agents
  • elliptinium